Article

Effect of Anti-inflammatory Treatment On Depression, Depressive Symptoms and Side Effects: a Systematic Review and Meta-analysis of Randomized Clinical Trials

European Psychiatry, Cambridge University Press (CUP), ISSN 1778-3585

Volume 30, 2015

DOI:10.1016/s0924-9338(15)30268-6, Dimensions: pub.1012399157,

Affiliations

Organisations

  1. (1) Centre for Register-based Research, Centre for Register-based Research, Århus V, Denmark
  2. (2) University of Copenhagen, grid.5254.6, KU
  3. (3) Research Department P, Aarhus University Hospital Risskov, Risskov, Denmark

Countries

Denmark

Continents

Europe

Description

IntroductionStudies have indicated antidepressant effects of anti-inflammatory treatment; however, results have been conflicting and side effects may contraindicate anti-inflammatory treatment.ObjectivesTo systematically review the antidepressant and possible side effects of anti-inflammatory interventions.AimsTo include trials published prior to December, 31st 2013, and evaluate depression scores after treatment and side effects.MethodsWe identified randomized, placebo-controlled trials assessing efficacy and side effects of pharmacological anti-inflammatory treatment in adults with depressive symptoms including adults fulfilling depression-criteria. We calculated standard mean difference (SMD) and Odds ratios (OR).Results10 publications covering 14 trials (n=6,262) were included: 10 on non-steroidal anti-inflammatory drugs (NSAIDs) (n=4,258) and four on cytokine-inhibitors (n=2,004). Anti-inflammatory treatment reduced depression (SMD=−0.54; 95%-CI:-1.08 to −0.01; I2=68%) and depressive symptoms (SMD=−0.27; 95%-CI:−0.53 to −0.01; I2=93%). Sub-analyses particularly emphasized antidepressant properties for the selective cyclooxygenase-2 inhibitor celecoxib in general (SMD=−0.29; 95%-CI: −0.49 to −0.08; I2=73%), on remission (OR=7.89; 95%-CI: 2.94 to 21.17; I2=0%) and response (OR=6.59; 95%-CI: 2.24 to 19.42; I2=0%). Among 6 studies (n=2,523), we found no evidence of an increased number of gastrointestinalor cardiovascular events after 6 weeks nor infections after 12 weeks of anti-inflammatory treatment. All trials were associated with high risk of bias.ConclusionsAnti-inflammatory treatment, in particular celecoxib, decreased depressive symptoms without increased risks of side effects. However, a high risk of bias and high heterogeneity made the mean estimate uncertain. This study supports a proof-of-concept concerning use of anti-inflammatory treatment in depression. Identification of subgroups that could benefit hereof might be warranted.

Research Categories

Main Subject Area

Fields of Research

Links & Metrics

NORA University Profiles

University of Copenhagen

Dimensions Citation Indicators

Times Cited: 2

Field Citation Ratio (FCR): 0.74